[96a5a0]: / output / allTrials / identified / NCT00003901_identified.json

Download this file

570 lines (570 with data), 26.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
{
"info": {
"nct_id": "NCT00003901",
"official_title": "A Prospective Study of the Prognostic Significance of Occult Metastases in the Patient With Resectable Non-Small Cell Lung Carcinoma",
"inclusion_criteria": "1. Patient must be ≥ 18 years old.\n2. Patient must have ECOG/Zubrod status < 3.\n3. Patient must have clinically resectable, NSCLC (squamous cell, adenocarcinoma, or large cell) and be clinical Stage I, IIa, IIb or IIIa, according to the 1998 staging system of the American Joint Commission on Cancer for lung cancer.\n4. Patient must have N1 or N2 disease. NOTE: Patient must undergo mediastinoscopy if preoperative studies suggest N3 disease.\n5. Patient must have a pathologic diagnosis (pre-operative or intra-operative) of NSCLC prior to registration.\n6. Patient must be anticipated to have a thoracotomy with the intention of a curative resection for primary NSCLC. NOTE: The preoperative assessment of resectability should, at a minimum, include a CT scan of the chest and upper abdomen, including the adrenal glands, within 60 days prior to registration.\n7. Patient must be medically fit for surgery.\n8. Patient must be a candidate for complete resection of the carcinoma via pneumonectomy, bilobectomy, lobectomy, or anatomic segmentectomy with or without sleeve resection.\n9. Patient or the patient's legally acceptable representative must provide a signed and dated written informed consent prior to registration and any study-related procedures.\n10. Patient must be available for follow-up.\n11. If the patient is a survivor of a prior cancer, all of the following criteria must apply:\n\n 1. Patient has undergone potentially curative therapy for all prior malignancies,\n 2. No evidence of any prior malignancies for at least 5 years with no evidence of recurrence (except for effectively treated basal cell or squamous carcinoma of the skin, carcinoma in-situ of the cervix that has been effectively treated by surgery alone, or lobular carcinoma in-situ of the ipsilateral or contralateral breast treated by surgery alone),\n 3. Patient is deemed by their treating physician to be at low risk for recurrence from prior malignancies.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "1. Patient has evidence of pleural effusion by physical assessment, lateral chest x-ray, or by chest CT scan.\n2. Patient has had ipsilateral thoracotomy or thoracoscopy within the past 5 years.\n3. Patient has received prior chemotherapy or radiotherapy for this cancer.\n4. Patient is considered a poor surgical risk due to non-malignant systemic disease (cardiovascular, renal, etc.) that would preclude the treatment options.\n5. Patient for whom the surgeon plans to perform only a wedge resection for treatment.",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Patient must be ≥ 18 years old.",
"criterions": [
{
"exact_snippets": "Patient must be ≥ 18 years old.",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "years"
}
}
]
}
]
},
{
"line": "2. Patient must have ECOG/Zubrod status < 3.",
"criterions": [
{
"exact_snippets": "ECOG/Zubrod status < 3",
"criterion": "ECOG/Zubrod status",
"requirements": [
{
"requirement_type": "status",
"expected_value": {
"operator": "<",
"value": 3,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "3. Patient must have clinically resectable, NSCLC (squamous cell, adenocarcinoma, or large cell) and be clinical Stage I, IIa, IIb or IIIa, according to the 1998 staging system of the American Joint Commission on Cancer for lung cancer.",
"criterions": [
{
"exact_snippets": "clinically resectable",
"criterion": "tumor resectability",
"requirements": [
{
"requirement_type": "resectability",
"expected_value": true
}
]
},
{
"exact_snippets": "NSCLC (squamous cell, adenocarcinoma, or large cell)",
"criterion": "NSCLC subtype",
"requirements": [
{
"requirement_type": "subtype",
"expected_value": [
"squamous cell",
"adenocarcinoma",
"large cell"
]
}
]
},
{
"exact_snippets": "clinical Stage I, IIa, IIb or IIIa",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"I",
"IIa",
"IIb",
"IIIa"
]
}
]
},
{
"exact_snippets": "according to the 1998 staging system of the American Joint Commission on Cancer for lung cancer",
"criterion": "staging system",
"requirements": [
{
"requirement_type": "system",
"expected_value": "1998 staging system of the American Joint Commission on Cancer for lung cancer"
}
]
}
]
},
{
"line": "4. Patient must have N1 or N2 disease. NOTE: Patient must undergo mediastinoscopy if preoperative studies suggest N3 disease.",
"criterions": [
{
"exact_snippets": "Patient must have N1 or N2 disease.",
"criterion": "disease stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"N1",
"N2"
]
}
]
},
{
"exact_snippets": "Patient must undergo mediastinoscopy ... if preoperative studies suggest N3 disease.",
"criterion": "mediastinoscopy requirement",
"requirements": [
{
"requirement_type": "condition",
"expected_value": "preoperative studies suggest N3 disease"
}
]
}
]
},
{
"line": "5. Patient must have a pathologic diagnosis (pre-operative or intra-operative) of NSCLC prior to registration.",
"criterions": [
{
"exact_snippets": "pathologic diagnosis ... of NSCLC",
"criterion": "NSCLC diagnosis",
"requirements": [
{
"requirement_type": "method",
"expected_value": "pathologic"
},
{
"requirement_type": "timing",
"expected_value": [
"pre-operative",
"intra-operative"
]
}
]
}
]
},
{
"line": "6. Patient must be anticipated to have a thoracotomy with the intention of a curative resection for primary NSCLC. NOTE: The preoperative assessment of resectability should, at a minimum, include a CT scan of the chest and upper abdomen, including the adrenal glands, within 60 days prior to registration.",
"criterions": [
{
"exact_snippets": "Patient must be anticipated to have a thoracotomy with the intention of a curative resection for primary NSCLC.",
"criterion": "anticipated thoracotomy",
"requirements": [
{
"requirement_type": "intention",
"expected_value": "curative resection for primary NSCLC"
}
]
},
{
"exact_snippets": "preoperative assessment of resectability should, at a minimum, include a CT scan of the chest and upper abdomen, including the adrenal glands, within 60 days prior to registration.",
"criterion": "preoperative assessment of resectability",
"requirements": [
{
"requirement_type": "inclusion",
"expected_value": [
"CT scan of the chest",
"CT scan of the upper abdomen",
"CT scan of the adrenal glands"
]
},
{
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 60,
"unit": "days prior to registration"
}
}
]
}
]
},
{
"line": "7. Patient must be medically fit for surgery.",
"criterions": [
{
"exact_snippets": "medically fit for surgery",
"criterion": "medical fitness for surgery",
"requirements": [
{
"requirement_type": "fitness",
"expected_value": true
}
]
}
]
},
{
"line": "8. Patient must be a candidate for complete resection of the carcinoma via pneumonectomy, bilobectomy, lobectomy, or anatomic segmentectomy with or without sleeve resection.",
"criterions": [
{
"exact_snippets": "Patient must be a candidate for complete resection of the carcinoma",
"criterion": "candidate for complete resection of carcinoma",
"requirements": [
{
"requirement_type": "eligibility",
"expected_value": true
}
]
},
{
"exact_snippets": "via pneumonectomy, bilobectomy, lobectomy, or anatomic segmentectomy with or without sleeve resection",
"criterion": "surgical procedure",
"requirements": [
{
"requirement_type": "type",
"expected_value": [
"pneumonectomy",
"bilobectomy",
"lobectomy",
"anatomic segmentectomy"
]
},
{
"requirement_type": "additional procedure",
"expected_value": "sleeve resection"
}
]
}
]
},
{
"line": "9. Patient or the patient's legally acceptable representative must provide a signed and dated written informed consent prior to registration and any study-related procedures.",
"criterions": [
{
"exact_snippets": "Patient or the patient's legally acceptable representative must provide a signed and dated written informed consent",
"criterion": "informed consent",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "10. Patient must be available for follow-up.",
"criterions": [
{
"exact_snippets": "Patient must be available for follow-up.",
"criterion": "patient availability for follow-up",
"requirements": [
{
"requirement_type": "availability",
"expected_value": true
}
]
}
]
},
{
"line": "11. If the patient is a survivor of a prior cancer, all of the following criteria must apply:",
"criterions": [
{
"exact_snippets": "survivor of a prior cancer",
"criterion": "prior cancer survivorship",
"requirements": [
{
"requirement_type": "status",
"expected_value": "survivor"
}
]
}
]
},
{
"line": "1. Patient has undergone potentially curative therapy for all prior malignancies,",
"criterions": [
{
"exact_snippets": "Patient has undergone potentially curative therapy for all prior malignancies",
"criterion": "prior malignancies",
"requirements": [
{
"requirement_type": "therapy status",
"expected_value": "potentially curative therapy undergone"
}
]
}
]
},
{
"line": "2. No evidence of any prior malignancies for at least 5 years with no evidence of recurrence (except for effectively treated basal cell or squamous carcinoma of the skin, carcinoma in-situ of the cervix that has been effectively treated by surgery alone, or lobular carcinoma in-situ of the ipsilateral or contralateral breast treated by surgery alone),",
"criterions": [
{
"exact_snippets": "No evidence of any prior malignancies for at least 5 years",
"criterion": "prior malignancies",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
},
{
"requirement_type": "time since last occurrence",
"expected_value": {
"operator": ">=",
"value": 5,
"unit": "years"
}
}
]
},
{
"exact_snippets": "no evidence of recurrence",
"criterion": "recurrence of malignancies",
"requirements": [
{
"requirement_type": "absence",
"expected_value": true
}
]
},
{
"exact_snippets": "except for effectively treated basal cell or squamous carcinoma of the skin",
"criterion": "basal cell or squamous carcinoma of the skin",
"requirements": [
{
"requirement_type": "treatment effectiveness",
"expected_value": true
}
]
},
{
"exact_snippets": "except for ... carcinoma in-situ of the cervix that has been effectively treated by surgery alone",
"criterion": "carcinoma in-situ of the cervix",
"requirements": [
{
"requirement_type": "treatment effectiveness",
"expected_value": true
},
{
"requirement_type": "treatment method",
"expected_value": "surgery alone"
}
]
},
{
"exact_snippets": "except for ... lobular carcinoma in-situ of the ipsilateral or contralateral breast treated by surgery alone",
"criterion": "lobular carcinoma in-situ of the breast",
"requirements": [
{
"requirement_type": "treatment method",
"expected_value": "surgery alone"
}
]
}
]
},
{
"line": "3. Patient is deemed by their treating physician to be at low risk for recurrence from prior malignancies.",
"criterions": [
{
"exact_snippets": "low risk for recurrence from prior malignancies",
"criterion": "recurrence risk from prior malignancies",
"requirements": [
{
"requirement_type": "risk level",
"expected_value": "low"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Patient has evidence of pleural effusion by physical assessment, lateral chest x-ray, or by chest CT scan.",
"criterions": [
{
"exact_snippets": "evidence of pleural effusion",
"criterion": "pleural effusion",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "by physical assessment",
"criterion": "pleural effusion detection method",
"requirements": [
{
"requirement_type": "method",
"expected_value": "physical assessment"
}
]
},
{
"exact_snippets": "by ... lateral chest x-ray",
"criterion": "pleural effusion detection method",
"requirements": [
{
"requirement_type": "method",
"expected_value": "lateral chest x-ray"
}
]
},
{
"exact_snippets": "by ... chest CT scan",
"criterion": "pleural effusion detection method",
"requirements": [
{
"requirement_type": "method",
"expected_value": "chest CT scan"
}
]
}
]
},
{
"line": "2. Patient has had ipsilateral thoracotomy or thoracoscopy within the past 5 years.",
"criterions": [
{
"exact_snippets": "ipsilateral thoracotomy or thoracoscopy",
"criterion": "ipsilateral thoracotomy or thoracoscopy",
"requirements": [
{
"requirement_type": "recency",
"expected_value": {
"operator": "<=",
"value": 5,
"unit": "years"
}
}
]
}
]
},
{
"line": "3. Patient has received prior chemotherapy or radiotherapy for this cancer.",
"criterions": [
{
"exact_snippets": "Patient has received prior chemotherapy",
"criterion": "prior chemotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Patient has received prior ... radiotherapy for this cancer",
"criterion": "prior radiotherapy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "4. Patient is considered a poor surgical risk due to non-malignant systemic disease (cardiovascular, renal, etc.) that would preclude the treatment options.",
"criterions": [
{
"exact_snippets": "poor surgical risk",
"criterion": "surgical risk",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "poor"
}
]
},
{
"exact_snippets": "non-malignant systemic disease (cardiovascular, renal, etc.)",
"criterion": "systemic disease",
"requirements": [
{
"requirement_type": "malignancy",
"expected_value": false
}
]
},
{
"exact_snippets": "non-malignant systemic disease (cardiovascular, renal, etc.)",
"criterion": "systemic disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "that would preclude the treatment options",
"criterion": "treatment options",
"requirements": [
{
"requirement_type": "feasibility",
"expected_value": false
}
]
}
]
},
{
"line": "5. Patient for whom the surgeon plans to perform only a wedge resection for treatment.",
"criterions": [
{
"exact_snippets": "surgeon plans to perform only a wedge resection",
"criterion": "planned surgical procedure",
"requirements": [
{
"requirement_type": "type",
"expected_value": "wedge resection"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}